Rituxan 50242-0053

Generic: Rituximab

Product NDC

50242-0053

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 26, 1997
Listing Expires: December 31, 2026
Application: BLA103705

Need to source Rituxan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Rituximab	10 mg/mL

Drug Class

CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]

Packaging Options(1)

50242-0053-06

1 VIAL, SINGLE-USE in 1 CARTON (50242-053-06) / 50 mL in 1 VIAL, SINGLE-USE

View →